Nf-κb dependent chemokine signaling in pancreatic cancer

Claudia Geismann, Heiner Schäfer, Jan Paul Gundlach, Charlotte Hauser, Jan Hendrik Egberts, Günter Schneider, Alexander Arlt*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Pancreatic cancer is one of the carcinomas with the worst prognoses, as shown by its fiveyear survival rate of 9%. Although there have been new therapeutic innovations, the effectiveness of these therapies is still limited, resulting in pancreatic ductal adenocarcinoma (PDAC) becoming the second leading cause of cancer-related death in 2020 in the US. In addition to tumor cell intrinsic resistance mechanisms, this disease exhibits a complex stroma consisting of fibroblasts, immune cells, neuronal and vascular cells, along with extracellular matrix, all conferring therapeutic resistance by several mechanisms. The NF-κB pathway is involved in both the tumor cell-intrinsic and microenvironment-mediated therapeutic resistance by regulating the transcription of a plethora of target genes. These genes are involved in nearly all scenarios described as the hallmarks of cancer. In addition to classical regulators of apoptosis, NF-κB regulates the expression of chemokines and their receptors, both in the tumor cells and in cells of the microenvironment. These chemokines mediate autocrine and paracrine loops among tumor cells but also cross-signaling between tumor cells and the stroma. In this review, we will focus on NF-κB-mediated chemokine signaling, with an emphasis on therapy resistance in pancreatic cancer.

Original languageEnglish (US)
Article number1445
Issue number10
StatePublished - Oct 2019

Bibliographical note

Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.


  • Apoptosis
  • Chemokine
  • Chemotherapy
  • Cytokine
  • Microenvironment
  • NF-κB
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Nf-κb dependent chemokine signaling in pancreatic cancer'. Together they form a unique fingerprint.

Cite this